PharmaJet Overview

  • Founded
  • 2005
Founded
  • Status
  • Private
  • Employees
  • 30
Employees
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $15M
Latest Deal Amount
  • Investors
  • 8

PharmaJet General Information

Description

Developer of needle-free devices intended to provide a standard of care in the vaccine delivery market. The company's devices use a narrow stream of fluid that flows intra-muscularly through the skin without a needle, thereby enabling physicians to eliminate needlestick injuries, needle reuse, cross-contamination, and sharps waste disposal.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Medical Supplies
Other Industries
Other Devices and Supplies
Other Healthcare Technology Systems
Primary Office
  • 400 Corporate Circle
  • Suite N
  • Golden, CO 80401
  • United States
+1 (888) 000-0000

PharmaJet Timeline

2018201920202021
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

PharmaJet Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
17. Later Stage VC 26-Apr-2021 $15M 0000 0000 Completed Generating Revenue
16. Later Stage VC (Series H) 10-Jun-2020 000 0000 0000 Completed Generating Revenue
15. Grant 17-Mar-2020 00.00 0000 Completed Generating Revenue
14. Later Stage VC (Series G) 31-Jan-2020 00.000 0000 0000 Completed Generating Revenue
13. Later Stage VC (Series G) 22-Jan-2019 00.000 0000 000.00 Completed Generating Revenue
12. Later Stage VC (Series F) 20-Apr-2018 00.000 000.00 000.00 Completed Generating Revenue
11. Later Stage VC (Series E) 21-Feb-2018 00.000 000.00 0000 Completed Generating Revenue
10. Accelerator/Incubator 01-Jan-2018 000.00 Completed Generating Revenue
9. Later Stage VC (Series D1) 07-May-2014 $1.5M $28.4M 0000 Completed Generating Revenue
8. Later Stage VC (Series D) 02-Jul-2013 $5.21M $26.9M 000.00 Completed Generating Revenue
To view PharmaJet’s complete valuation and funding history, request access »

PharmaJet Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series H 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 0.000
Series G1 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series F 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 0.000
Series E 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series D1 000,000 00.000000 00.00 00.00 00.00 00 00.00 0.000
Series D 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series C2 000,000 00.000000 00.00 00.00 00.00 00 00.00 0.000
Series C1 000,000 00.000000 00.00 00.00 00.00 00 00.00 0.000
Series C 1,171,421 $0.000010 $0.28 $3.5 $3.5 1x $3.5 4.64%
Series B1 897,620 $0.000010 $0.52 $6.51 $6.51 1x $6.51 3.55%
To view PharmaJet’s complete cap table history, request access »

PharmaJet Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of needle-free devices intended to provide a standard of care in the vaccine delivery market. The company's de
Medical Supplies
Golden, CO
30 As of 2021
0000
000 0000-00-00
0000000000 0 0000

00000000

iam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commo
0000000 00000000
Dijon, France
00 As of 0000
000.00
00000000000 000.00

000000 0

is aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
00000 0000000 000 00000000
Cambridge, MA
00 As of 0000
0000
000000000 - 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

PharmaJet Competitors (6)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Crossject Formerly VC-backed Dijon, France 00 000.00 00000000000 000.00
000000 00000000000 Venture Capital-Backed Cambridge, MA 00 0000 000000000 - 0000
0000000 0000000 00 Corporate Backed or Acquired Portland, OR 00 000.00 000000&0 000.00
00000000 000000000 Venture Capital-Backed Nes Ziona, Israel 00 0000 000000 - 000 0000
000000000 Formerly VC-backed Wijnegem, Belgium 0 00000 000000&0 00000
To view PharmaJet’s complete competitors history, request access »

PharmaJet Executive Team (7)

Name Title Board Seat Contact Info
Ronald Lowy Chairman
Jeffrey Jordan Chief Financial Officer
Chris Cappello Chief Executive Officer, President & Board Member
Heather Callender-Potters Co-Founder, Chief Advocate and Shareholder Relations Officer, Vice Chairman & Board Member
Kathleen Callender Co-Founder
You’re viewing 5 of 7 executive team members. Get the full list »

PharmaJet Board Members (13)

Name Representing Role Since
Chris Cappello PharmaJet Chief Executive Officer, President & Board Member 000 0000
Cody Smith PharmaJet Board Member 000 0000
Heather Callender-Potters PharmaJet Co-Founder, Chief Advocate and Shareholder Relations Officer, Vice Chairman & Board Member 000 0000
John Buckley PharmaJet Board Member 000 0000
Kevin Lorenz PharmaJet Board Member 000 0000
You’re viewing 5 of 13 board members. Get the full list »

PharmaJet Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

PharmaJet Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
ERG Enterprises Real Estate Minority 000 0000 000000 0
Medical CBRN Defense Consortium Government 000 0000 000000 0
California Institute for Quantitative Biosciences Accelerator/Incubator Minority 000 0000 000000 0
Stout Street Capital Venture Capital Minority 000 0000 000000 0
3Lines Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 8 investors. Get the full list »